LSBCF (LakeShore Biopharma Co) Total Tax Payable: $0.39 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Total Tax Payable?

LakeShore Biopharma Co LSBCF Total Tax Payable is $0.39 Mil as of Mar. 2025.

LakeShore Biopharma Co's Total Tax Payable for the quarter that ended in Mar. 2025 was $0.39 Mil.

LakeShore Biopharma Co's quarterly Total Tax Payable declined from Mar. 2024 ($0.42 Mil) to Sep. 2024 ($0.00 Mil) but then increased from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($0.39 Mil).

LakeShore Biopharma Co's annual Total Tax Payable increased from Mar. 2023 ($0.06 Mil) to Mar. 2024 ($0.42 Mil) but then declined from Mar. 2024 ($0.42 Mil) to Mar. 2025 ($0.39 Mil).

LakeShore Biopharma Co Total Tax Payable Related Terms

LakeShore Biopharma Co Total Tax Payable Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Tax Payable Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Tax Payable
0.25 0.19 0.06 0.42 0.39

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only 0.06 0.00 0.42 0.00 0.39

LakeShore Biopharma Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of $0.39 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Tax Payable of $0.39 Mil as of Mar. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Tax Payable too high?
LakeShore Biopharma Co's current Total Tax Payable is $0.39 Mil.
How does LakeShore Biopharma Co's Total Tax Payable compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Tax Payable of $0.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Tax Payable is $0.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Tax Payable of $0.39 Mil. The current Total Tax Payable is $0.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Tax Payable is $0.39 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.